GDRX News
Archived Headlines
- US IPO Week Ahead: The September IPO calendar stays Good(Rx) and busy in an 8 IPO week 09/18/20
- Let the good times roll: GoodRx sets terms for $900 million IPO 09/14/20
- Fall 2020 US IPO Preview: Tech Unicorns Leap Through the IPO Window 09/04/20
- US IPO Week Ahead: The quiet before the post-Labor Day IPO storm 08/28/20
- Prescription drug comparison platform GoodRx files for an estimated $750 million IPO 08/28/20
Fall 2021 US IPO Preview: An Active End to a Record Year
The US IPO market has already posted its busiest year since the internet bubble in 2000, and we expect issuance to stay active in the fall. With broader equity markets at all-time highs and a burgeoning IPO pipeline of private unicorns, many long-awaited names...read more
Updated: Renaissance Capital's 3Q 2020 US IPO Market Review
IPO Frenzy Drives Busiest Third Quarter Since 2000 The US IPO market had its busiest third quarter by deal count since the Dot-com era, with 81 IPOs raising $28.5 billion. The high volume...read more
US IPO Weekly Recap: Health and tech dominate the calendar in an 11 IPO week
September activity remained high as 11 IPOs and eight SPACs went public this past week. The IPO market shows no signs of slowing with eight IPOs and 18 SPACS submitting initial filings. Prescription drug price comparison platform GoodRx...read more
Prescription drug comparison platform GoodRx prices IPO well above the range at $33
GoodRx Holdings, which operates a prescription drug price comparison platform, raised $1.1 billion by offering 34.6 million shares (32% insider) at $33, above the range of $24 to $28. GoodRx Holdings plans to list on the Nasdaq under the symbol GDRX. Morgan...read more